Pinta Treatment & Management

Updated: Feb 06, 2023
  • Author: Nelson Ivan Agudelo Higuita, MD, DTM&H, CTH®; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Treatment

Medical Care

The World Health Organization (WHO) recommends treatment of pinta with a single-dose intramuscular injection of long-acting benzathine penicillin (1.2 MU for adults; 0.6 MU for children). Penicillin renders lesions noninfectious within 24 hours. [2]

Skin lesions heal slowly.

After treatment, nontreponemal titers should decline and can (but do not always) revert to negative.

The WHO started a campaign to eradicate yaws (caused by T pallidum pertenue) by 2020 based on the mass treatment of endemic communities with an oral dose of azithromycin. T carateum is most likely sensitive to azithromycin, and this intervention could therefore have a concomitant effect on pinta in regions of Latin America where both yaws and pinta might still coexist. [2]  As of 2023, these efforts are ongoing; the WHO recommends integrating yaws eradication activities with neglected tropical disease (NTD) programmes (for MDA) and Skin NTDs (active surveillance). The WHO published a framework on integrated control of skin NTDs in June 2022 to assist countries with eradication efforts.

Next:

Surgical Care

Surgery has no role in pinta treatment.

Previous
Next:

Complications

Early pinta lesions usually improve with penicillin treatment, although the late changes of pinta are irreversible, often causing stigmatization in communities. [2]

Previous
Next:

Prevention

Treatment of close contacts and household members is recommended to prevent the development of infection. [1]

Previous
Next:

Long-Term Monitoring

Long-term monitoring of pinta is unnecessary. Treatment resolves early lesions and, in persons with late infections, arrests progression. A fall in two or more dilutions in the nontreponemal tests may be seen after treatment with penicillin, but serology results might not revert to negative. [1]

Previous